Cargando…

Bicyclic Boronate VNRX-5133 Inhibits Metallo- and Serine-β-Lactamases

[Image: see text] The bicyclic boronate VNRX-5133 (taniborbactam) is a new type of β-lactamase inhibitor in clinical development. We report that VNRX-5133 inhibits serine-β-lactamases (SBLs) and some clinically important metallo-β-lactamases (MBLs), including NDM-1 and VIM-1/2. VNRX-5133 activity ag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krajnc, Alen, Brem, Jürgen, Hinchliffe, Philip, Calvopiña, Karina, Panduwawala, Tharindi D., Lang, Pauline A., Kamps, Jos J. A. G., Tyrrell, Jonathan M., Widlake, Emma, Saward, Benjamin G., Walsh, Timothy R., Spencer, James, Schofield, Christopher J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6767355/ https://www.ncbi.nlm.nih.gov/pubmed/31454231 http://dx.doi.org/10.1021/acs.jmedchem.9b00911

Ejemplares similares

Will morphing boron-based inhibitors beat the β-lactamases?
por: Krajnc, Alen, et al.
Publicado: (2019)

Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
por: Liu, Bin, et al.
Publicado: (2019)

Bicyclic Boronates as Potent Inhibitors of AmpC, the Class C β-Lactamase from Escherichia coli
por: Lang, Pauline A., et al.
Publicado: (2020)

VNRX-5133 (Taniborbactam), a Broad-Spectrum Inhibitor of Serine- and Metallo-β-Lactamases, Restores Activity of Cefepime in Enterobacterales and Pseudomonas aeruginosa
por: Hamrick, Jodie C., et al.
Publicado: (2020)

Structural Basis of Metallo-β-lactamase Inhibition by N-Sulfamoylpyrrole-2-carboxylates
por: Farley, Alistair J. M., et al.
Publicado: (2021)

Correction to “Structural Basis of Metallo-β-lactamase Inhibition by N-Sulfamoylpyrrole-2-carboxylates”
por: Farley, Alistair J. M., et al.
Publicado: (2021)

Profiling interactions of vaborbactam with metallo-β-lactamases
por: Langley, Gareth W., et al.
Publicado: (2019)

Safety and Pharmacokinetics in Human Volunteers of Taniborbactam (VNRX-5133), a Novel Intravenous β-Lactamase Inhibitor
por: Dowell, James A., et al.
Publicado: (2021)

Safety and Pharmacokinetics of Taniborbactam (VNRX-5133) with Cefepime in Subjects with Various Degrees of Renal Impairment
por: Dowell, James A., et al.
Publicado: (2022)

1318. Pharmacokinetics and Safety of Cefepime-Taniborbactam (formerly Cefepime/VNRX-5133) in Subjects with Renal Impairment
por: Geibel, Brooke, et al.
Publicado: (2020)

Studies on the Reactions of Biapenem with VIM Metallo β-Lactamases and the Serine β-Lactamase KPC-2
por: Lucic, Anka, et al.
Publicado: (2022)

1360. Antimicrobial Activity of Cefepime in Combination with VNRX-5133 Against a Global Collection of Enterobacteriaceae Including Resistant Phenotypes
por: Hackel, Meredith, et al.
Publicado: (2018)

1405. Efficacy of the Human-Simulated Regimen (HSR) of Cefepime (FEP)/VNRX-5133 Combination Against Serine β-Lactamase-Producing Gram-negative Bacteria in the Neutropenic Murine Thigh Infection Model
por: Abdelraouf, Kamilia, et al.
Publicado: (2018)

Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates
por: Brem, Jürgen, et al.
Publicado: (2016)

1401. A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Pharmacokinetics of Single and Repeat Doses of VNRX-5133 in Healthy Subjects
por: Geibel, Brooke, et al.
Publicado: (2018)

203. Activity of Cefepime in Combination with Taniborbactam (formerly VNRX-5133) Against Pseudomonas aeruginosa from a Global 2018-2020 Surveillance Collection
por: Hackel, Meredith, et al.
Publicado: (2021)

1370. Cefepime/VNRX-5133 Broad-Spectrum Activity Is Maintained Against Emerging KPC- and PDC-Variants in Multidrug-Resistant K. pneumoniae and P. aeruginosa
por: Daigle, Denis, et al.
Publicado: (2018)

1395. Defining the Magnitude of AUC:MIC Driver for Efficacy of the β-Lactamase Inhibitor VNRX-5133 When Combined with Cefepime Against KPC- and VIM/NDM-Producing Enterobacteriaceae and P. aeruginosa
por: Daigle, Denis, et al.
Publicado: (2018)

Computational and biological profile of boronic acids for the detection of bacterial serine- and metallo-β-lactamases
por: Santucci, Matteo, et al.
Publicado: (2017)

Cyclobutanone Mimics of Intermediates in Metallo‐β‐Lactamase Catalysis
por: Abboud, Martine I., et al.
Publicado: (2018)

Use of ferrous iron by metallo-β-lactamases
por: Cahill, Samuel T., et al.
Publicado: (2016)

Crystal structures of VIM‐1 complexes explain active site heterogeneity in VIM‐class metallo‐β‐lactamases
por: Salimraj, Ramya, et al.
Publicado: (2018)

The Chemical Biology of Human Metallo-β-Lactamase Fold Proteins
por: Pettinati, Ilaria, et al.
Publicado: (2016)

Discovery of VNRX-7145 (VNRX-5236 Etzadroxil): An Orally Bioavailable β-Lactamase Inhibitor for Enterobacterales Expressing Ambler Class A, C, and D Enzymes
por: Trout, Robert E., et al.
Publicado: (2021)

Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
por: Hinchliffe, Philip, et al.
Publicado: (2023)

Assay Platform for Clinically Relevant Metallo-β-lactamases
por: van Berkel, Sander S., et al.
Publicado: (2013)

Interaction of Avibactam with Class B Metallo-β-Lactamases
por: Abboud, Martine I., et al.
Publicado: (2016)

Structure activity relationship studies on rhodanines and derived enethiol inhibitors of metallo-β-lactamases
por: Zhang, Dong, et al.
Publicado: (2018)

In vitro activity of the orally bioavailable ceftibuten/VNRX-7145 (VNRX-5236 etzadroxil) combination against a challenge set of Enterobacterales pathogens carrying molecularly characterized β-lactamase genes
por: Mendes, Rodrigo E, et al.
Publicado: (2021)

Structural Basis of Metallo-β-Lactamase Inhibition by Captopril Stereoisomers
por: Brem, Jürgen, et al.
Publicado: (2015)

Monitoring Conformational Changes in the NDM-1 Metallo-β-lactamase by (19)F NMR Spectroscopy**
por: Rydzik, Anna M, et al.
Publicado: (2014)

(19)F‐NMR Reveals the Role of Mobile Loops in Product and Inhibitor Binding by the São Paulo Metallo‐β‐Lactamase
por: Abboud, Martine I., et al.
Publicado: (2017)

Biochemical characterization of New Delhi metallo-β-lactamase variants reveals differences in protein stability
por: Makena, Anne, et al.
Publicado: (2015)

High-Throughput Crystallography Reveals Boron-Containing Inhibitors of a Penicillin-Binding Protein with Di- and Tricovalent Binding Modes
por: Newman, Hector, et al.
Publicado: (2021)

Spectrum of Beta-Lactamase Inhibition by the Cyclic Boronate QPX7728, an Ultrabroad-Spectrum Beta-Lactamase Inhibitor of Serine and Metallo-Beta-Lactamases: Enhancement of Activity of Multiple Antibiotics against Isogenic Strains Expressing Single Beta-Lactamases
por: Lomovskaya, Olga, et al.
Publicado: (2020)

NMR-filtered virtual screening leads to non-metal chelating metallo-β-lactamase inhibitors
por: Li, Guo-Bo, et al.
Publicado: (2017)

1055. ARGONAUT-IV: Susceptibility of Carbapenem-resistant Klebsiellae to Ceftibuten/VNRX-5236
por: Mack, Andrew R, et al.
Publicado: (2021)

Structural and Kinetic Studies of the Potent Inhibition of Metallo-β-lactamases by 6-Phosphonomethylpyridine-2-carboxylates
por: Hinchliffe, Philip, et al.
Publicado: (2018)

Monitoring protein-metal binding by (19)F NMR – a case study with the New Delhi metallo-β-lactamase 1
por: Rydzik, Anna M., et al.
Publicado: (2020)

Studying the active-site loop movement of the São Paolo metallo-β-lactamase-1
por: Brem, Jürgen, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_8g6hkbgd526eoblqlhpn7dqa89